SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): July 31, 1997 (July 31, 1997)
LASERSIGHT INCORPORATED
-----------------------
Exact name of registrant as specified in its charter
Delaware
State or other jurisdiction of incorporation
0-19671 65-0273162
------- ----------
Commission File Number I.R.S. Employer
Identification No.
12161 Lackland Road, St. Louis, Missouri 63146
----------------------------------------------
Address of Principal Executive Offices
Registrant's telephone number, including area code: (314) 469-3220
<PAGE>
Item 5. Other Events.
The press release issued by LaserSight Incorporated dated July 31, 1997 is
incorporated by reference herein.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits
Exhibit 99. Press Release dated July 31, 1997
SIGNATURES
----------
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
LaserSight Incorporated
Date: July 31, 1997 By: /s/ Michael R. Farris
------------------------
Michael R. Farris
Chief Executive Officer
EXHIBIT 99
NASDAQ SYMBOL: LASE
LASERSIGHT UPDATES IBM PATENT PURCHASE STATUS
St. Louis, MO -- July 31, 1997 -- (NASDAQ: LASE) As previously announced on
February 20, 1997, LaserSight Incorporated entered into a patent purchase
agreement with International Business Machines Corporation (NYSE: IBM) for
fundamental claim stem patents related to ultraviolet light ophthalmic products
and procedures for laser vision correction.
LaserSight today said it is working with several potential funding sources,
including other industry participants, and anticipates the transaction will
close in August, subject to the successful completion of the financing
arrangements.
LaserSight Incorporated is a holding company with operating subsidiaries engaged
in the business of laser manufacturing and international sales, third-party
managed vision care administration, ophthalmic practice management, and health
and vision care consulting services.
This press release contains forward-looking statements regarding future events
and future performance of the Company that involve risks and uncertainties that
could materially affect actual results. Investors should refer to documents that
the Company files from time to time with the Securities and Exchange Commission
for a description of certain factors that could cause actual results to vary
from current expectations and the forward-looking statements contained in this
press release. Such filings include, without limitation, the Company's Form
10-K, Form 10-Q and Form 8-K reports.
For additional information please contact: Marti Benfield,
Manager, Investor Relations
LaserSight Incorporated
(314) 469-3220
